A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study

A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study

COVID-19 is a global pandemic, with over 50 million confirmed cases and 1.2 million deaths as of November 11, 2020. No therapies or vaccines so far are recommended to treat or prevent the new coronavirus. A novel traditional Chinese medicine formula, Taiwan Chingguan Yihau (NRICM101), has been admin...

Full description

Bibliographic Details
Main Authors: Keng-Chang Tsai, Yi-Chia Huang, Chia-Ching Liaw, Chia-I Tsai, Chun-Tang Chiou, Chien-Jung Lin, Wen-Chi Wei, Sunny Jui-Shan Lin, Yu-Hwei Tseng, Kuo-Ming Yeh, Yi-Ling Lin, Jia-Tsrong Jan, Jian-Jong Liang, Chun-Che Liao, Wen-Fei Chiou, Yao-Haur Kuo, Shen-Ming Lee, Ming-Yung Lee, Yi-Chang Su
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Biomedicine & Pharmacotherapy
Subjects:
SARS-CoV-2
Traditional Chinese medicine
NRICM101
Spike protein
3CL protease
Cytokine storm
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332220312294

Internet

http://www.sciencedirect.com/science/article/pii/S0753332220312294

Similar Items